Empro Group Inc. Ordinary shares (EMPG) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Empro Group Inc. Ordinary shares stock (EMPG) is currently trading at $17.36. Empro Group Inc. Ordinary shares PE ratio is 192.89. Empro Group Inc. Ordinary shares PS ratio (Price-to-Sales) is 26.08. WallStSmart rates EMPG as Underperform.
- EMPG PE ratio analysis and historical PE chart
- EMPG PS ratio (Price-to-Sales) history and trend
- EMPG intrinsic value — DCF, Graham Number, EPV models
- EMPG stock price prediction 2025 2026 2027 2028 2029 2030
- EMPG fair value vs current price
- EMPG insider transactions and insider buying
- Is EMPG undervalued or overvalued?
- Empro Group Inc. Ordinary shares financial analysis — revenue, earnings, cash flow
- EMPG Piotroski F-Score and Altman Z-Score
- EMPG analyst price target and Smart Rating
Empro Group Inc.
📊 No data available
Try selecting a different time range
EMPG Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Empro Group Inc. Ordinary shares (EMPG)
EMPG trades 2746% above its Graham fair value of $0.61, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Empro Group Inc. Ordinary shares (EMPG) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in return on equity, operating margin, revenue growth. Concerns around market cap and price/sales. Mixed signals suggest waiting for clearer direction before acting.
Empro Group Inc. Ordinary shares (EMPG) Key Strengths (3)
Every $100 of shareholder equity generates $66 in profit
Keeps $36 of every $100 in revenue after operating costs
Revenue surging 141.60% year-over-year
Empro Group Inc. Ordinary shares (EMPG) Areas to Watch (5)
Very expensive at 26.1x annual revenue
Very expensive at 93.7x book value
Very low institutional interest at 0.90%
Micro-cap company with very limited liquidity and high volatility
Decent profitability, keeps $14 per $100 revenue
Supporting Valuation Data
Empro Group Inc. Ordinary shares (EMPG) Detailed Analysis Report
Overall Assessment
This company scores 45/100 in our Smart Analysis, earning a D grade. Out of 8 metrics analyzed, 3 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Return on Equity, Operating Margin, Revenue Growth. Profitability is solid with Return on Equity at 66.30%, Operating Margin at 36.10%. Growth metrics are encouraging with Revenue Growth at 141.60%.
The Bear Case
The primary concerns are Price/Sales, Price/Book, Institutional Own.. Some valuation metrics including Price/Sales (26.08), Price/Book (93.70) suggest expensive pricing. Profitability pressure is visible in Profit Margin at 13.70%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Sales improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 66.30% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 141.60% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Price/Sales and Price/Book are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
EMPG Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
EMPG's Price-to-Sales ratio of 26.08x sits near its historical average of 23.94x (20th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 26.08x set in Oct 2025, and 426% above its historical low of 4.96x in Jul 2025. Over the past 12 months, the PS ratio has expanded from ~5.0x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Empro Group Inc. Ordinary shares (EMPG) · HEALTHCARE › MEDICAL DISTRIBUTION
The Big Picture
Empro Group Inc. Ordinary shares is a strong growth company balancing expansion with improving profitability. Revenue reached 5M with 142% growth year-over-year. Profit margins of 13.7% are healthy, with room for further expansion as the business scales.
Key Findings
Revenue growing at 142% YoY, reaching 5M. This pace significantly outperforms most MEDICAL DISTRIBUTION peers.
ROE of 66.3% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Free cash flow is -16,470, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Margin expansion: can Empro Group Inc. Ordinary shares push profit margins above 15% as the business scales?
Growth sustainability: can Empro Group Inc. Ordinary shares maintain 142%+ revenue growth, or will competition slow it down?
Valuation compression risk at a P/E of 192.9x. Any growth miss could trigger a sharp correction.
Debt management: total debt of 2M is significantly higher than cash (108,428). Monitor refinancing risk.
Bottom Line
Empro Group Inc. Ordinary shares offers an attractive blend of growth (142% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:12:17 AM
About Empro Group Inc. Ordinary shares(EMPG)
NASDAQ
HEALTHCARE
MEDICAL DISTRIBUTION
USA
Empro Group Inc., through its subsidiary, sells healthcare and beauty products in Malaysia and internationally. The company is headquartered in Shah Alam, Malaysia.